Business Standard

Glenmark Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 Disclosure pursuant to Regulation 30 of Securities and Exchange Board of India (...Read More10/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed - Release Cap...Read More12/06/2024
Transcript Of Investor Day 2024 The transcript of Investor Day 2024 held on Thursday May 30 2024 has been upload...Read More04/06/2024
Audio Recording Of The Glenmark Pharmaceuticals Limited - Investor Day 2024 Audio Recording of Investor Day 2024 held on 30th May 202431/05/2024
Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for the financial year 2023-2428/05/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to Regulation 30 and 46 read with Part A of Schedule III of the SEBI (L...Read More27/05/2024
Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation Q4 FY 23-24 and FY 23-24.24/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find enclosed herewith press release and management discussion & analysis...Read More24/05/2024
Corporate Action-Board to consider Dividend The Board has recommended dividend @ 250% i.e. Rs. 2.5/- per share (face value o...Read More24/05/2024
Appointment Of Cost Auditor For FY 24-25 The Board has approved the appointment of M/s. RA & Co. Cost Auditor of the Com...Read More24/05/2024
Board Meeting Outcome for Financial Results And Declaration Of Dividend Please find enclosed financial results for the quarter and year ended March 31 2...Read More24/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Glenmark and BeiGene Enter into an Agreement for Marketing and Distribution of T...Read More21/05/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation This is to inform you that Glenmark Pharmaceuticals Limited will host an Investo...Read More17/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Glenmark Pharmaceuticals receives ANDA approval for Brimonidine Tartrate and Tim...Read More17/05/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Enclosed please find herewith details of Earnings Call slated for Monday May 27 ...Read More15/05/2024
Closure of Trading Window The trading window was closed from March 31 2024 to May 26 2024 (both days inclu...Read More14/05/2024
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2024 And Recommending Dividend If Any On Equity Shares For The Year Ended March 31 2024 GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of D...Read More14/05/2024
Announcement under Regulation 30 (LODR)-Acquisition Intimation of Securities Subscription & Shareholders Agreement and Power Purchas...Read More10/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Glenmark receives ANDA approval for Acetaminophen and lbuproden Tablets29/04/2024
Announcement under Regulation 30 (LODR)-Credit Rating With reference to the subject mentioned above kindly find enclosed rating ration...Read More25/04/2024

Load more